St. Jude Medical Announces Key Findings at ACC.12 – the 61st Annual Scientific Session and Expo of the American College of Cardiology

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced key clinical findings that will be presented at ACC.12, the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC), taking place March 24 to March 27 in Chicago at the McCormick Place Convention Center.

Back to news